Adrenergic Blockers for Cardiac Changes in Early Parkinson's Disease (Protocol 53136)

NCT03775096 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

REM Sleep Behavior Disorder
Pre-motor Parkinson Disease
Symptomatic Parkinson Disease

Interventions

DRUG: Carvedilol

Sponsor

Michele Tagliati, MD